Hepatic lipase gene –514 C/T polymorphism and premature coronary heart disease

European Journal of Cardiovascular Prevention & Rehabilitation

Volumn 9, Issue 2, 2002, Pages 105-113

  Ji, Juying ^a   Herbisona, Carly E ^a   Mamotte, Cyril D S ^a   Burke, Valerie ^a   Taylor, Roger R ^a   van Bockxmeer, Frank M ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

coronary disease; genes; lipoproteins

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE FACTORS; AUSTRALIA; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LIPASE; LIVER; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TIME FACTORS; TRIGLYCERIDES;

EID: 0036116229     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/174182670200900206     Document Type: Article

References (32)

1. Stahnke G, Sprengel R, Augustin J, Will H. Human hepatic triglyceride lipase: Cdna cloning, amino acid sequence and expression in a cultured cell line. Differentiation 1987; 35: 45–52.
2. Datta S, Luo CC, Li WH, Van Tuinen P, Ledbetter DH, Brown MA, et al Human hepatic lipase. Cloned cDNA sequence, restriction fragment length polymorphisms, chromosomal localization, and evolutionary relationships with lipoprotein lipase and pancreatic lipase. J Biol Chem 1988; 263: 1107–1110.
3. Deckelbaum RJ, Ramakrishnan R, Eisenberg S, Olivecrona T, Bengtsson-Olivecrona G. Triacylglycerol and phospholipid hydrolysis in human plasma lipoproteins: Role of lipoprotein and hepatic lipase. Biochemistry 1992; 31: 8544–8551.
4. Shafi S, Brady SE, Bensadoun A, Havel RJ. Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. J Lipid Res 1994; 35: 709–720.
5. Beisiegel U. New aspects of the role of plasma lipases in lipoprotein catabolism and atherosclerosis. Atherosclerosis 1996; 124: 1–8.
6. Whitman SC, Miller DB, Wolfe BM, Hegele RA, Huff MW. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: The role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans. J Lipid Res 1997; 38: 1318–1333.
7. Cohen JC, Vega GL, Grundy SM. Hepatic lipase: New insights from genetic and metabolic studies. Curr Opin Lipidol 1999; 10: 259–267.
8. Kuusi T, Saarinen P, Nikkilä EA. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein 2 in man. Atherosclerosis 1980; 36: 589–593.
9. Guerra R, Wang J, Grundy SM, Cohen JC. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci 1997; 94: 4532–4537.
10. Jansen H, Verhoeven AJ, Weeks L, Kastelein JJ, Halley DJ, van den Ouweland A, et al Common C-to-Tsubstitution at position −480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol 1997; 17: 2837–2842.
11. Tahvanainen E, Syvänne M, Frick MH, Murtomaki-Repo S, Antikainen M, Kesaniemi YA, et al Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene for the LOCAT Study Investigators. J Clin Invest 1998; 101: 956–960.
12. Vega GL, Clark LT, Tang A, Marcovina S, Grundy SM, Cohen JC. Hepatic lipase activity is lower in African American men than in white American men: Effects of 5 flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res 1998; 39: 228–232.
13. Shohet RV, Vega GL, Anwar A, Cigarroa JE, Grundy SM, Cohen JC. Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations. Arterioscler Thromb Vasc Biol 1999; 19: 1975–1978.
14. De Oliveira E, Silva ER, Kong M, Han Z, Starr C, Kass EM, Juo SH, et al Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females. J Lipid Res 1999; 40: 1211–1221.
15. Botma G-J, Verhoeve AJM, Jansen H. Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor. Atheroscler 2001; 625: 625–632.
16. Zambon A, Deeb SS, Brown BG, Hokanson JE, Brunzell JD. Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment. Circulation 2001; 103: 792–798.
17. Jansen H, Chu G, Ehnholm C, Dallongeville J, Nicaud V, Talmud P.J., The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII: B. European Atherosclerosis Research Study (EARS) II. Arterioscler Thromb Vasc Biol 1999; 19: 303–308.
18. Grundy SM, Vega GL, Otvos JD, Rainwater DL, Cohen JC. Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence. J Lipid Res 1999; 40: 229–234.
19. Couture P, Otvos JD, Cupples LA, Lahoz C, Wilson PW, Schaefer EJ, et al Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles. The Framingham offspring study. Arterioscler Thromb Vasc Biol 2000; 20: 815–822.
20. Juo S.-H.H., Han Z, Smith JD, Colangelo L, Liu K. Promoter polymorphisms of the hepatic lipase gene influence HDL2 but not HDL3 in African American men: CARDIA study. J Lipid Res 2001; 42: 258–264.
21. Mamotte CD, van Bockxmeer FM, Taylor RR. PI a1/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty. Am J Cardiol 1998; 82: 13–16.
22. Cai SJ, Wong DM, Chen SH, Chan L. Structure of the human hepatic triglyceride lipase gene. Biochemistry 1989; 28: 8966–8971.
23. Ameis D, Stahnke G, Kobayashi J, McLean J, Lee G, Buscher M, et al Isolation and characterization of the human hepatic lipase gene. J Biol Chem 1989; 265: 6552–6555.
24. van't Hooft F.M., Lundahl B, Ragogna F, Karpe F, Olivecrona G, Hamsten A. Functional characterization of 4 polymorphisms in promoter region of hepatic lipase gene. Arterioscler Thromb Vasc Biol 2000; 20: 1335–1339.
25. Vega GL, Gao J, Bersot TP, Mahley RW, Verstraete R, Grundy SM, et al The −514 polymorphism in the hepatic lipase gene (LIPC) does not influence androgen-mediated stimulation of hepatic lipase. J Lipid Res 1998; 39: 1520–1524.
26. Tan KCB, Shiu SWM, Chu BYM. Effects of gender, hepatic lipase gene polymorphism and type 2 diabetes mellitus on hepatic lipase activity in Chinese. Atherosclerosis 2001; 157: 233–239.
27. Jansen H, Waterworth DM, Nicaud V, Ehnholm C, Talmud PJ. Interaction of the common apolipoprotein C-Ill (APOC3–482C>T) and hepatic lipase (LIPC −514C>T) promoter variants affects glucose tolerance in young adults. European Atherosclerosis Research Study II (EARS-II). Ann Hum Genet 2001; 65: 237–243.
28. Oka K, Ishimura-Oka K, Chu M-J, Chan L. Transcription of the human hepatic lipase gene is modulated by multiple negative elements in HepG2 cells. Gene 1996; 180: 69–80.
29. Chang S-F, Scharf J-G, Will H. Structural and functional analysis of the promoter of the hepatic lipase gene. Eur J Biochem 1997; 247: 148–159.
30. Deeb SS, Peng R. The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity. J Lipid Res 2000; 41: 155–158.
31. Cohen JC, Wang Z, Grundy SM, Stoesz MR, Guerra R. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest 1994; 94: 2377–2384.
32. Pihlajamaki J, Karjalainen L, Karhapaa P, Vauhkonen I, Taskinen MR, Deeb SS, et al G-250A Substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2000; 20: 1789–1795.